Metabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition-Reference-Cited by-同舟云学术

Metabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition

Published:2017-04-17 Issue:34 Volume:36 Page:4859-4874
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Hendrick E,Peixoto P,Blomme A,Polese C,Matheus N,Cimino J,Frère A,Mouithys-Mickalad A,Serteyn D,Bettendorff L,Elmoualij B,De Tullio P,Eppe G,Dequiedt F,Castronovo V,Mottet D

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/onc2017103.pdf

Reference52 articles.

1. Mottet D, Castronovo V . Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis 2008; 25: 183–189.

2. Nebbioso A, Carafa V, Benedetti R, Altucci L . Trials with ‘epigenetic’ drugs: an update. Mol Oncol 2012; 6: 657–682.

3. Qiu T, Zhou L, Zhu W, Wang T, Wang J, Shu Y et al. Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials. Future Oncol 2013; 9: 255–269.

4. Rangwala S, Zhang C, Duvic M . HDAC inhibitors for the treatment of cutaneous T-cell lymphomas. Future Med Chem 2012; 4: 471–486.

5. Sawas A, Radeski D, O’Connor OA . Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review. Ther Adv Hematol 2015; 6: 202–208.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor targeting with Apatinib-loaded nanoparticles and sonodynamic combined therapy;Current Molecular Medicine;2023-06-13

2. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities;Cancer Communications;2022-10-20

3. HDACs and the epigenetic plasticity of cancer cells: Target the complexity;Pharmacology & Therapeutics;2022-10

4. Silent information regulator 1 suppresses epithelial-to-mesenchymal transition in lung cancer cells via its regulation of mitochondria status;Life Sciences;2021-09

5. Insights Into the Function and Clinical Application of HDAC5 in Cancer Management;Frontiers in Oncology;2021-06-10